XML 24 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation Plans
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
10.
Stock-Based Compensation Plans
 
During the three months ended March 31, 2019, the Company recognized $366,000 of compensation expense associated with stock option and restricted stock awards granted in years 2015 through 2019. During the three months ended March 31, 2018, the Company recognized $351,000 of compensation expense associated with stock option and restricted stock awards granted in years 2014 through 2017.
 
The following table summarizes the Company’s stock option activity for the three-month period ended March 31, 2019:
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
Weighted
 
 
Average
 
 
 
 
 
 
 
 
 
Average
 
 
Remaining
 
 
Aggregate
 
 
 
 
 
 
Exercise
 
 
Contractual
 
 
Intrinsic
 
 
 
Shares
 
 
Price
 
 
Term (Years)
 
 
Value*
 
Outstanding at December 31, 2018
 
 
1,173,620
 
 
$
27.96
 
 
 
 
 
 
 
 
 
Granted
 
 
2,500
 
 
$
28.77
 
 
 
 
 
 
 
 
 
Exercised
 
 
(3,250
)
 
$
27.97
 
 
 
 
 
 
 
 
 
Forfeited or expired
 
 
(1,430
)
 
$
30.43
 
 
 
 
 
 
 
 
 
Outstanding at March 31, 2019
 
 
1,171,440
 
 
$
27.96
 
 
 
3.9
 
 
$
4,316,000
 
Exercisable at March 31, 2019
 
 
688,757
 
 
$
26.91
 
 
 
2.1
 
 
$
2,789,000
 
  
*
The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of the Company's stock on March 29, 2019, the last trading day of the quarter, of $30.96 and the exercise price multiplied by the number of in-the-money outstanding and exercisable stock options.
 
The following table summarizes the Company’s stock option exercise activity for the three months ended March 31, 2019 and 2018:
 
 
 
Three Months Ended March 31,
 
 
 
2019
 
 
2018
 
 
 
(Dollars in thousands)
 
Total intrinsic value of stock options exercised
 
$
11
 
 
$
501
 
Cash received from stock option exercises
 
$
7
 
 
$
2,884
 
Income tax benefit from the exercise of stock options
 
$
3
 
 
$
130
 
  
        The following table summarizes the Company’s restricted stock award activity for the three-month period ended March 31, 2019:
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
Weighted
 
 
Average
 
 
 
 
 
 
Shares of
 
 
Average
 
 
Remaining
 
 
Aggregate
 
 
 
Restricted
 
 
Grant Date
 
 
Contractual
 
 
Intrinsic
 
 
 
Stock
 
 
Fair Value
 
 
Term (Years)
 
 
Value*
 
Non-vested at December 31, 2018
 
 
61,480
 
 
$
30.74
 
 
 
 
 
 
 
 
 
Issued
 
 
600
 
 
$
28.77
 
 
 
 
 
 
 
 
 
Vested
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
Forfeited
 
 
-
 
 
 
-
 
 
 
 
 
 
 
 
 
Non-vested at March 31, 2019
 
 
62,080
 
 
$
30.72
 
 
 
2.4
 
 
$
1,922,000
 
 
*
The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of the Company's stock on March 29, 2019, the last trading day of the quarter, of $30.96 multiplied by the number of non-vested restricted shares outstanding.